Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-22-026246
Filing Date
2022-10-11
Accepted
2022-10-11 16:23:55
Documents
1
Period of Report
2022-10-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_166551982032663.html 4  
1 FORM 4 wf-form4_166551982032663.xml 4 6251
  Complete submission text file 0001628280-22-026246.txt   7665
Mailing Address C/O GLOBAL BLOOD THERAPEUTICS, INC. 400 EAST JAMIE COURT SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address
Morrison Scott W (Reporting) CIK: 0001662426 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39614 | Film No.: 221304329

Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Issuer) CIK: 0001819790 (see all company filings)

EIN.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)